Pilgrim Partners Asia Pte Ltd Takes Position in agilon health, inc. (NYSE:AGL)

Pilgrim Partners Asia Pte Ltd bought a new stake in shares of agilon health, inc. (NYSE:AGL) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 31,600 shares of the company’s stock, valued at approximately $60,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Intech Investment Management LLC acquired a new position in shares of agilon health during the 3rd quarter worth about $228,000. MetLife Investment Management LLC lifted its position in shares of agilon health by 114.8% in the third quarter. MetLife Investment Management LLC now owns 167,789 shares of the company’s stock valued at $659,000 after acquiring an additional 89,675 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of agilon health by 6.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company’s stock worth $2,515,000 after acquiring an additional 37,725 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of agilon health during the third quarter worth approximately $28,000. Finally, Centiva Capital LP acquired a new position in agilon health in the 3rd quarter valued at $651,000.

agilon health Stock Performance

Shares of AGL opened at $4.14 on Friday. The company has a market capitalization of $1.70 billion, a PE ratio of -4.40 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The company’s fifty day moving average price is $3.74 and its 200 day moving average price is $3.00.

Wall Street Analysts Forecast Growth

AGL has been the subject of a number of recent research reports. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Stifel Nicolaus raised their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Macquarie began coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target for the company. Finally, Sanford C. Bernstein boosted their price objective on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.95.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.